Drug Testing Locations - Big Sur, CA

Drug Testing in Big Sur, CA

Big Sur, California Statistics

Monterey County, where Big Sur is located, had a significant rate of opioid prescriptions, with 4.3 per 1,000 population in 2021.

In 2021, Monterey County reported an increase in fentanyl-related deaths, with a 127% spike from the previous year.

Alcohol use disorders were reported in 8% of individuals seeking treatment in Monterey County in 2022.

The 2022 Monterey County Health Department report showed that 12% of high school students in the county used marijuana in the past 30 days.

In 2021, Monterey County saw a 20% increase in drug-related arrests compared to the previous year.

Monterey County's mental health services noted a rise in substance abuse-related calls by 34% in 2022.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Big Sur, CA & Drug Testing Policies

Employers in Big Sur, CA, recognize the impact of drug use on workplace safety and productivity. Many organizations have implemented drug testing policies as preventive measures. These policies typically include pre-employment screening, random drug testing, and procedures for testing after workplace incidents.

Businesses in the hospitality sector, which is prominent in Big Sur, often adhere to guidelines by the U.S. Department of Labor and the California Department of Industrial Relations. These policies not only aim to maintain a safe work environment but also provide support services for employees struggling with substance use.

Government Efforts with Drug Problems in Big Sur, CA

The Monterey County Health Department has been proactive in curbing drug abuse issues in Big Sur, CA. Through initiatives like the "Safe Prescribing" program, they aim to reduce opioid misuse and promote safer opioid prescribing practices among healthcare providers.

To support recovery and rehabilitation, the county collaborates with state agencies to offer treatment and prevention programs. Resources from the Monterey County Health Department focus on education, support hotlines, and community workshops to raise awareness about addiction risks.

Local Drug Busts & News in Big Sur, CA

Big Sur, CA, has seen several local drug busts in recent years. These operations are often coordinated by the Monterey County Sheriff's Office in collaboration with state and federal agencies. A notable event in 2022 led to the seizure of significant quantities of methamphetamine and arrests of key figures in a local drug network.

Community-driven initiatives have been hosting events to tackle the drug problem. The annual "Big Sur Drug Awareness Weekend" involves workshops and awareness campaigns to educate locals about the risks of drug abuse and promote healthy lifestyles as an alternative.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Big Sur, CA. Trusted by employers nationwide for accurate results and exceptional service.

California DOT/Non DOT Physicals

California Vision Tests

California Audiograms

California Respirator Fit Tests

California Lift Tests

California Background Checks

Clinical Testing Services

TB Testing in CA

Diabetes Testing in CA

Infectious Disease Testing in CA

Sickle Cell Anemia Testing in CA

Women/Men's Health Testing in CA

Resources & Citations

Monterey County Health Department

California Department of Health Care Services

SAMHSA National Helpline

Alcoholics Anonymous

Narcotics Anonymous

ATTC Network

California Health & Wellness

CCAPP

Partnership to End Addiction

ReachOut USA

Drug Testing Near Big Sur, CA

Marina, CA

Chualar, CA

Spreckels, CA

Pacific Grove, CA

Sand City, CA

Seaside, CA

Monterey, CA

Del Monte Forest, CA

Del Rey Oaks, CA

Toro, CA

Carmel-by-the-Sea, CA

Carmel, CA

Carmel Valley, CA

Carmel Valley Village, CA

Coastal, CA

Frequently Asked Questions

Customer Reviews